Ad is loading...
GMEYX vs RNPCX
GMEYX vs RNPCX Comparison
Open Charts GMEYX vs RNPCX
GuideStone Funds Impact Equity Instl
Price$12.17
Change-$0.20 (-1.62%)
VolumeN/A
Net Assets118.47M
American Funds New Perspective R3
Price$62.82
Change-$0.76 (-1.20%)
VolumeN/A
Net Assets147.51B
GMEYX vs RNPCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 148B vs. GMEYX (118M). GMEYX pays higher dividends than RNPCX: GMEYX (0.67) vs RNPCX (0.58). GMEYX was incepted earlier than RNPCX: GMEYX (2 years) vs RNPCX (23 years). GMEYX is a more actively managed with annual turnover of: 44.00 vs. RNPCX (17.00). RNPCX has a lower initial minimum investment than GMEYX: RNPCX (250) vs GMEYX (1000000). RNPCX annual gain was more profitable for investors over the last year : 9.95 vs. GMEYX (3.84).
| GMEYX | RNPCX | GMEYX / RNPCX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 2 years | 23 years | - |
| Gain YTD | 5.826 | 4.578 | 127% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 118M | 148B | 0% |
| Annual Yield % from dividends | 0.67 | 0.58 | 116% |
| Returns for 1 year | 3.84 | 9.95 | 39% |
| Returns for 3 years | N/A | 13.46 | - |
| Returns for 5 years | N/A | 31.90 | - |
| Returns for 10 years | N/A | 69.55 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MIG | 21.32 | 0.08 | +0.38% |
| VanEck IG Corporate ETF | |||
| SPEM | 40.35 | -0.07 | -0.17% |
| SPDR® Portfolio Emerging Markets ETF | |||
| PBE | 68.11 | -0.25 | -0.36% |
| Invesco Biotechnology & Genome ETF | |||
| FSMD | 41.02 | -1.03 | -2.45% |
| Fidelity Small-Mid Multifactor ETF | |||
| MMLG | 31.35 | -1.06 | -3.28% |
| First Trust Multi-Manager Large Gr ETF | |||